Day: February 13, 2024

CORRECTION – Mullen Reports Strongest Fiscal Quarter in Company’s History for Three Months Ended Dec. 31, 2023

CORRECTION – Mullen Reports Strongest Fiscal Quarter in Company’s History for Three Months Ended Dec. 31, 2023

Mullen Automotive Inc. (NASDAQ: MULN), is updating its press release with certain corrections as described further below. There are no changes to the financial results for the three months ended Dec. 31, 2023. The prior press release as corrected is set forth in its entirety below. Company reports financial results and current business update Stockholders’ equity $271,814,097.00 as of December 31, 2023 BREA, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) — via IBN — Mullen Automotive Inc. (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announces financial results for the three months ended Dec. 31, 2023, and a business update. Commenting on the results for the three months ended Dec. 31, 2023, and recent Company developments, CEO and chairman David Michery stated, “We are coming off our strongest quarter to...

Continue reading

Clairvest Reports Fiscal 2024 Third Quarter Results

Clairvest Reports Fiscal 2024 Third Quarter Results

TORONTO, Feb. 13, 2024 (GLOBE NEWSWIRE) — Clairvest Group Inc. (TSX: CVG) today reported results for the fiscal 2024 third quarter and nine months ended December 31, 2023. (All figures are in Canadian dollars unless otherwise stated) Highlights December 31, 2023 book value was $1,150.3 million or $78.38 per share compared with $1,181.0 million or $78.61 per share as at September 30, 2023 Net loss for the quarter ended December 31, 2023 was $5.0 million or $0.34 per share Net loss for the nine months ended December 31, 2023 was $29.5 million or $1.97 per share Clairvest repurchased for cancellation 340,100 shares from a passive shareholder for a total cost of $25.2 million Clairvest’s book value was $1,150.3 million or $78.38 per share as at December 31, 2023, compared with $1,181.0 million or $78.61 per share as at September...

Continue reading

Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2024

Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2024

FDA approved LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL Additional USAFA funding commitment from the U.S. Air Force Academy, intended to advance the ATI-1701 program toward an IND submission to the FDA Engaging regulatory authorities to align on ATI-1801 development plans HALIFAX, Nova Scotia, Feb. 13, 2024 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense products, today announced its financial and operational results for the third quarter of its fiscal year 2024, which ended on December 31, 2023. All figures are stated in Canadian dollars unless otherwise stated. In recent months, we’ve achieved significant milestones by solidifying ATI-1701 government...

Continue reading

ESGEN Acquisition Corp. Announces Registration Statement Effectiveness in Connection with Business Combination with Sunergy Renewables

ESGEN Acquisition Corp. Announces Registration Statement Effectiveness in Connection with Business Combination with Sunergy Renewables

ESGEN Acquisition Corp. to Host Extraordinary General Meeting of Shareholders on March 6, 2024 to Approve Business Combination DALLAS and NEW PORT RICHEY, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) — ESGEN Acquisition Corp. (“ESGEN”) (Nasdaq: ESACU, ESAC, ESACW), a publicly-traded special purpose acquisition company, and Sunergy Renewables, LLC (“Sunergy”), a leading Florida-based provider of residential solar and energy efficiency solutions, today announced that ESGEN’s registration statement on Form S-4, as amended (the “Registration Statement”) in connection with the previously announced proposed business combination (the “Business Combination”) with Sunergy has been declared effective by the U.S. Securities and Exchange Commission (the “SEC”). Following the closing of the Business Combination, the combined company will change its...

Continue reading

NanoXplore Reports Results for its Q2-2024

NanoXplore Reports Results for its Q2-2024

MONTREAL, Feb. 13, 2024 (GLOBE NEWSWIRE) — NanoXplore Inc. (“NanoXplore” or “the Corporation”) (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, reported today financial results for the three and six-month period ended December 31, 2023. All amounts in this press release are in Canadian dollars, unless otherwise stated. HIGHLIGHTS Total revenues of $29,063,024 in Q2-2024 compared to $31,725,122 in Q2-2023, representing an 8% decrease due to a 6-week strike at one of our major customers; Gross margin on revenues from customers of 19.4% in Q2-2024 compared to 17.8% in Q2-2023 and of 19.5% for YTD 2024 compared to 14.9% for YTD 2023; Adjusted EBITDA* of $416,000 in Q2-2024 compared to $141,300 in Q2-2023 for the advanced materials, plastics and composite products; Adjusted EBITDA* of -$508,806 in Q2-2024 compared to...

Continue reading

Western Announces Fourth Quarter 2023 Results

Western Announces Fourth Quarter 2023 Results

VANCOUVER, British Columbia, Feb. 13, 2024 (GLOBE NEWSWIRE) — Western Forest Products Inc. (TSX: WEF) (“Western” or the “Company”) reported a net loss of $14.3 million in the fourth quarter of 2023, as compared to a net loss of $17.4 million in the third quarter of 2023, and net loss of $21.4 million in the fourth quarter of 2022. Results in the fourth quarter of 2023 reflect lower realized pricing and shipment volumes on a stronger lumber sales mix, offset by lower stumpage rates as compared to the same period last year. Adjusted EBITDA was negative $1.2 million in the fourth quarter of 2023, as compared to negative $11.6 million in the third quarter of 2023, and negative $11.9 million in the fourth quarter of 2022. Operating loss prior to restructuring and other items was $14.4 million in the fourth quarter of 2023, as compared...

Continue reading

Campbell and Sovos Brands Certify Substantial Compliance with Second Request from FTC; Begins the Start of 30-Day Waiting Period

Campbell and Sovos Brands Certify Substantial Compliance with Second Request from FTC; Begins the Start of 30-Day Waiting Period

CAMDEN, N.J. and LOUISVILLE, Colo., Feb. 13, 2024 (GLOBE NEWSWIRE) — Campbell Soup Company (NYSE: CPB) and Sovos Brands, Inc. (NASDAQ: SOVO) today announced that both companies have certified substantial compliance with the Request for Additional Information and Documentary Materials (“Second Request”) issued by the Federal Trade Commission (FTC) regarding Campbell’s proposed acquisition of Sovos Brands. The certification of substantial compliance triggers the start of a 30-day waiting period which is expected to expire on March 11, 2024, after which the sale can be finalized. Subject to the satisfaction or waiver of customary closing conditions, the companies expect to complete the transaction within days of the March 11, 2024 expiration date. “We’re excited to be one step closer to completing the acquisition and welcoming...

Continue reading

Natural Alternatives International, Inc. Announces 2024 Q2 and YTD Results

Natural Alternatives International, Inc. Announces 2024 Q2 and YTD Results

CARLSBAD, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) — Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $3.1 million, or $0.52 per diluted share, on net sales of $25.2 million for the second quarter of fiscal year 2024 compared to net income of $1.8 million, or $0.31 per diluted share, in the second quarter of the prior fiscal year. Net sales during the three months ended December 31, 2023, decreased $17.1 million, or 40%, to $25.2 million as compared to $42.3 million recorded in the comparable prior year period. During the same period, private-label contract manufacturing sales decreased 44% to $23.0 million. Private-label contract manufacturing sales decreased primarily due to reduced orders...

Continue reading

<div>Farmers & Merchants Bancorp, Inc. Reports 2023 Fourth-Quarter and Full-Year Financial Results</div>

Farmers & Merchants Bancorp, Inc. Reports 2023 Fourth-Quarter and Full-Year Financial Results

ARCHBOLD, Ohio, Feb. 13, 2024 (GLOBE NEWSWIRE) — Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO) today reported financial results for the 2023 fourth quarter and twelve months ended December 31, 2023. 2023 Fourth Quarter Financial and Operating Highlights (on a year-over-year basis unless noted): 83 consecutive quarters of profitability Net income was $5.5 million, or $0.41 per basic and diluted share Asset quality remains strong as nonperforming loans were 0.87% of total loans Net charge-offs to average loans were 0.03% Allowance for credit losses was 111.95% of nonperforming loans Tier 1 leverage ratio was 8.20% Opened first bank office in Michigan and new regional headquarters in Fort Wayne, Indiana Added Ian D. Boyce to the Board of Directors of both the Company and the Bank Realigned organizational structure to support...

Continue reading

GXO Reports Fourth Quarter and Full Year 2023 Results

GXO Reports Fourth Quarter and Full Year 2023 Results

Highlights Fourth quarter revenue of $2.6 billion; net income attributable to GXO of $73 million; adjusted EBITDA1 of $193 million; diluted EPS of $0.61 and adjusted diluted EPS1 of $0.70 Full year revenue of $9.8 billion; net income attributable to GXO of $229 million; adjusted EBITDA1 of $741 million; diluted EPS of $1.92 and adjusted diluted EPS1 of $2.59 Full year cash flows from operations of $558 million, equivalent to 244% of net income attributable to GXO, and free cash flow1 of $302 million, equivalent to 41% of adjusted EBITDA1 Announced 2024 guidance2: Organic revenue growth1 of 2%-5% Adjusted EBITDA1 of $760-$790 million Adjusted diluted earnings per share1 of $2.70-$2.90 Free cash flow conversion1 of 30%-40% of adjusted EBITDA1 Business Highlights Signed more than $1 billion annualized revenue in 2023; ~40% from outsourcing ~$600...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.